Overview of COVID-19 and Its Vaccination and Its Relation to Dermatology

The COVID-19 pandemic has highlighted the connection between systemic health and dermatology, with skin manifestations such as rashes, livedo reticularis, and telogen effluvium serving as indicators of the disease. The COVID-19 vaccine, while crucial in preventing severe illness, has also been associated with dermatological side effects, including delayed injection site reactions and autoimmune-related skin conditions. Most vaccine-induced skin reactions are minor and self-resolving, but recognizing them is important to alleviate patient concerns and reduce vaccine hesitancy. Dermatologists have been essential in diagnosing and managing COVID-19-related skin issues and addressing vaccine-related concerns, underscoring the need for multidisciplinary public health approaches. Ongoing research into skin biomarkers and vaccine effects will further integrate dermatology into systemic disease management, enhancing patient outcomes as the pandemic transitions to an endemic phase.